OTTAWA, Dec. 21, 2018 /CNW/ -
IssueHealth Canada is warning Canadians that Pace, a shot-sized drink that isbeing promoted as an alcohol substitute, contains an active ingredient—5-methoxy-2-aminoindane (MEAI)—that is similar in structure to amphetamines and may pose serious health risks. Pace is being sold online by the Diet Alcohol Corporation of the
While the product is being promoted as a beverage by the company, this product would be regulated as a drug in Canada and would require approval before it could be sold to Canadians. This product has not been assessed by Health Canada for safety, effectiveness or quality, and its sale has not been authorized by Heath Canada.
Who is affected
What consumers should do
What Health Canada is doingHealth Canada is working with the Canada Border Services Agency to help prevent the importation of this product. Should Canadian retailers or distributors of this product be identified, Health Canada will take appropriate action and inform Canadians.
BackgroundMEAI (5-methoxy-2-aminoindane) is a controlled substance regulated under the Controlled Drugs and Substances Act. It is similar in structure to amphetamines. It is not approved for use as a drug in Canada, and it has not been reviewed by Health Canada for safety, effectiveness and quality. Very little is known about the effects of this substance, particularly when used long-term, in high doses or together with other substances that cause impairment. No clinical studies have been performed to study its effects in humans, but users have reported impaired coordination, inebriation, dizziness, sweating, nausea and potential effects on the heart. A safe dose to consume has also not been determined.
Également disponible en français
SOURCE Health Canada
Subscribe to our Free Newsletters!